Evidence map›Paper›PMID 41501552›Full record

ArticleCommunications biology2026

Pathology and viral evolutionary dynamics in a hamster model of persistent SARS-CoV-2 infection.

Wanting Wei, Makoto Kuroda, Yanan Liu, Shun Iida, Sangam Kandel, Heather Machovech, Yuichiro Hirata, Tadaki Suzuki, Katia Koelle, Zhongde Wang and 3 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wanting Wei *Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Makoto Kuroda *Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Yanan LiuDepartment of Animal, Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University, Logan, UT, USA.
Shun IidaDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2258-9031
Sangam KandelDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.ORCID http://orcid.org/0000-0002-2875-6462
Heather MachovechDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
Yuichiro HirataDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0009-0009-2503-1077
Tadaki SuzukiDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3820-9542
Katia KoelleDepartment of Biology, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-0254-6141
Zhongde WangDepartment of Animal, Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University, Logan, UT, USA.ORCID http://orcid.org/0000-0003-2441-4729
Thomas C FriedrichDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA. tfriedri@wisc.edu.ORCID http://orcid.org/0000-0001-9831-6895
Yoshihiro KawaokaDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.ORCID http://orcid.org/0000-0001-5061-8296
Peter J HalfmannDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA. peter.halfmann@wisc.edu.ORCID http://orcid.org/0000-0002-1648-1625

Funding

COVID-19 comorbidity studies in Syrian hamster modelsR21AI164001 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KAWAOKA, YOSHIHIRO · 2021 to 2022
$428k
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) R21AI164001Japan Agency for Medical Research and Development (AMED) JP223fa627003Japan Agency for Medical Research and Development (AMED) JP243fa727002Japan Agency for Medical Research and Development (AMED) JP24fk0108637Japan Agency for Medical Research and Development (AMED) JP24wm0125008Japan Agency for Medical Research and Development (AMED) JP25fk0108732NIAID NIH HHS R21 AI164001
6 · The paper itself

Abstract

SARS-CoV-2 infection typically resolves within weeks, but rare cases of prolonged replication-sometimes exceeding a year-have been documented, particularly in immunocompromised individuals. These persistent infections pose health risks and may give rise to highly divergent variants, yet the underlying biology remains poorly understood. Here, we describe a model of SARS-CoV-2 persistence using transgenic Syrian hamsters (males) lacking the interleukin-2 receptor gamma subunit (IL2rg). Infection with the XBB.1.16 variant led to efficient viral replication in respiratory tissues by two weeks after infection, with dissemination to other sites, including the intestinal tract. Viral titers remained high in multiple tissues at 100 days after infection. Longitudinal oral swab sequencing revealed dynamic shifts in intrahost single-nucleotide variant (iSNV) frequencies, with constellations of iSNVs rising and falling together, consistent with strong genetic linkage. Synonymous and nonsynonymous mutations accumulated at similar rates, suggesting genetic drift as the dominant evolutionary force. Tissue- and swab-derived sequences revealed extensive within-host diversity and hinted at tissue-specific evolutionary trajectories. This model enables detailed investigation of SARS-CoV-2 persistence and within-host viral evolution and provides a controlled system to study how long-term replication in tissue reservoirs may contribute to viral diversification.

Indexed as

COVID-19Persistent InfectionSARS-CoV-2AnimalsAnimals, Genetically ModifiedCricetinaeDisease Models, AnimalEvolution, MolecularMaleMesocricetusMutationVirus Replication

Identifiers

PMID41501552
PMCPMC12881346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.